Commonwealth Equity Services’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$503K Sell
56,179
-9,562
-15% -$76.2K ﹤0.01% 3200
2025
Q4
$396K Hold
65,741
﹤0.01% 3390
2025
Q3
$375K Sell
65,741
-304
-0.5% -$1.55K ﹤0.01% 3434
2025
Q2
$333K Sell
66,045
-1,038
-2% -$5.57K ﹤0.01% 3497
2025
Q1
$435K Sell
67,083
-283
-0.4% -$2.52K ﹤0.01% 3140
2024
Q4
$494K Sell
67,366
-1,469
-2% -$11.6K ﹤0.01% 2958
2024
Q3
$516K Buy
68,835
+5,600
+9% +$48.6K ﹤0.01% 2869
2024
Q2
$563K Sell
63,235
-3,083
-5% -$29.6K ﹤0.01% 2736
2024
Q1
$672K Sell
66,318
-100
-0.2% -$1.02K ﹤0.01% 2563
2023
Q4
$668K Sell
66,418
-1,024
-2% -$9.36K ﹤0.01% 2472
2023
Q3
$632K Sell
67,442
-2,342
-3% -$33.4K ﹤0.01% 2399
2023
Q2
$1.71M Hold
69,784
﹤0.01% 1734
2023
Q1
$1.62K Sell
69,784
-9,384
-12% -$240K ﹤0.01% 1691
2022
Q4
$2M Sell
79,168
-6,130
-7% -$150K ﹤0.01% 1500
2022
Q3
$1.64M Buy
85,298
+523
+0.6% +$13.3K ﹤0.01% 1558
2022
Q2
$2.16M Hold
84,775
0.01% 1395
2022
Q1
$2.18M Sell
84,775
-845
-1% -$25.1K 0.01% 1445
2021
Q4
$3.58M Sell
85,620
-1,621
-2% -$63.5K 0.01% 1107
2021
Q3
$3.8M Sell
87,241
-23,088
-21% -$1,000K 0.01% 1031
2021
Q2
$5.22M Buy
110,329
+20,901
+23% +$950K 0.01% 833
2021
Q1
$4.58M Sell
89,428
-57,376
-39% -$3.09M 0.01% 829
2020
Q4
$3.93M Sell
146,804
-514
-0.3% -$16.7K 0.01% 848
2020
Q3
$5.06M Sell
147,318
-12,121
-8% -$522K 0.02% 641
2020
Q2
$6.53M Buy
+159,439
New +$5.35M 0.02% 538

Other funds holding VIR